Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI

Update your browser to view ScienceDirect.

Request details:

Request ID: 8d12b4b47ef1239e-LAX
IP: 116.62.10.13
UTC time: 2024-10-11T23:42:18+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4